213 related articles for article (PubMed ID: 19088039)
1. Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer.
Ogino S; Kirkner GJ; Nosho K; Irahara N; Kure S; Shima K; Hazra A; Chan AT; Dehari R; Giovannucci EL; Fuchs CS
Clin Cancer Res; 2008 Dec; 14(24):8221-7. PubMed ID: 19088039
[TBL] [Abstract][Full Text] [Related]
2. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.
Ogino S; Nosho K; Kirkner GJ; Kawasaki T; Meyerhardt JA; Loda M; Giovannucci EL; Fuchs CS
Gut; 2009 Jan; 58(1):90-6. PubMed ID: 18832519
[TBL] [Abstract][Full Text] [Related]
3. A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases.
Ogino S; Nosho K; Irahara N; Kure S; Shima K; Baba Y; Toyoda S; Chen L; Giovannucci EL; Meyerhardt JA; Fuchs CS
Clin Cancer Res; 2009 Jul; 15(13):4431-8. PubMed ID: 19549773
[TBL] [Abstract][Full Text] [Related]
4. Cohort study of fatty acid synthase expression and patient survival in colon cancer.
Ogino S; Nosho K; Meyerhardt JA; Kirkner GJ; Chan AT; Kawasaki T; Giovannucci EL; Loda M; Fuchs CS
J Clin Oncol; 2008 Dec; 26(35):5713-20. PubMed ID: 18955444
[TBL] [Abstract][Full Text] [Related]
5. A cohort study of p27 localization in colon cancer, body mass index, and patient survival.
Ogino S; Shima K; Nosho K; Irahara N; Baba Y; Wolpin BM; Giovannucci EL; Meyerhardt JA; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1849-58. PubMed ID: 19505918
[TBL] [Abstract][Full Text] [Related]
6. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
Kosumi K; Hamada T; Zhang S; Liu L; da Silva A; Koh H; Twombly TS; Mima K; Morikawa T; Song M; Nowak JA; Nishihara R; Saltz LB; Niedzwiecki D; Ou FS; Zemla T; Mayer RJ; Baba H; Ng K; Giannakis M; Zhang X; Wu K; Giovannucci EL; Chan AT; Fuchs CS; Meyerhardt JA; Ogino S
Eur J Cancer; 2019 Apr; 111():82-93. PubMed ID: 30826660
[TBL] [Abstract][Full Text] [Related]
7. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
Baba Y; Nosho K; Shima K; Goessling W; Chan AT; Ng K; Chan JA; Giovannucci EL; Fuchs CS; Ogino S
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):822-31. PubMed ID: 20200425
[TBL] [Abstract][Full Text] [Related]
8. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
Ogino S; Nosho K; Baba Y; Kure S; Shima K; Irahara N; Toyoda S; Chen L; Kirkner GJ; Wolpin BM; Chan AT; Giovannucci EL; Fuchs CS
Am J Gastroenterol; 2009 Aug; 104(8):2047-56. PubMed ID: 19513025
[TBL] [Abstract][Full Text] [Related]
9. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.
Morikawa T; Kuchiba A; Yamauchi M; Meyerhardt JA; Shima K; Nosho K; Chan AT; Giovannucci E; Fuchs CS; Ogino S
JAMA; 2011 Apr; 305(16):1685-94. PubMed ID: 21521850
[TBL] [Abstract][Full Text] [Related]
10. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.
Ogino S; Nosho K; Kirkner GJ; Kawasaki T; Chan AT; Schernhammer ES; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2008 Dec; 100(23):1734-8. PubMed ID: 19033568
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.
Ogino S; Shima K; Baba Y; Nosho K; Irahara N; Kure S; Chen L; Toyoda S; Kirkner GJ; Wang YL; Giovannucci EL; Fuchs CS
Gastroenterology; 2009 Apr; 136(4):1242-50. PubMed ID: 19186181
[TBL] [Abstract][Full Text] [Related]
12. p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis.
Ogino S; Nosho K; Shima K; Baba Y; Irahara N; Kirkner GJ; Hazra A; De Vivo I; Giovannucci EL; Meyerhardt JA; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2513-21. PubMed ID: 19723919
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
Mima K; Nishihara R; Yang J; Dou R; Masugi Y; Shi Y; da Silva A; Cao Y; Song M; Nowak J; Gu M; Li W; Morikawa T; Zhang X; Wu K; Baba H; Giovannucci EL; Meyerhardt JA; Chan AT; Fuchs CS; Qian ZR; Ogino S
Clin Cancer Res; 2016 Aug; 22(15):3841-8. PubMed ID: 26957558
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin B expression and survival in colon cancer: implications for molecular detection of neoplasia.
Chan AT; Baba Y; Shima K; Nosho K; Chung DC; Hung KE; Mahmood U; Madden K; Poss K; Ranieri A; Shue D; Kucherlapati R; Fuchs CS; Ogino S
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2777-85. PubMed ID: 20833970
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.
Barault L; Charon-Barra C; Jooste V; de la Vega MF; Martin L; Roignot P; Rat P; Bouvier AM; Laurent-Puig P; Faivre J; Chapusot C; Piard F
Cancer Res; 2008 Oct; 68(20):8541-6. PubMed ID: 18922929
[TBL] [Abstract][Full Text] [Related]
16. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
[TBL] [Abstract][Full Text] [Related]
17. Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
Ogino S; Brahmandam M; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS
Neoplasia; 2006 Jun; 8(6):458-64. PubMed ID: 16820091
[TBL] [Abstract][Full Text] [Related]
18. Calcium intake and colon cancer risk subtypes by tumor molecular characteristics.
Keum N; Liu L; Hamada T; Qian ZR; Nowak JA; Cao Y; da Silva A; Kosumi K; Song M; Nevo D; Wang M; Chan AT; Meyerhardt JA; Fuchs CS; Wu K; Ogino S; Nishihara R; Zhang X
Cancer Causes Control; 2019 Jun; 30(6):637-649. PubMed ID: 30963391
[TBL] [Abstract][Full Text] [Related]
19. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.
Momen-Heravi F; Masugi Y; Qian ZR; Nishihara R; Liu L; Smith-Warner SA; Keum N; Zhang L; Tchrakian N; Nowak JA; Yang W; Ma Y; Bowden M; da Silva A; Wang M; Fuchs CS; Meyerhardt JA; Ng K; Wu K; Giovannucci E; Ogino S; Zhang X
Int J Cancer; 2017 Dec; 141(12):2471-2479. PubMed ID: 28856682
[TBL] [Abstract][Full Text] [Related]
20. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
